These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 23611776

  • 21. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
    Franco GC, Kajiya M, Nakanishi T, Ohta K, Rosalen PL, Groppo FC, Ernst CW, Boyesen JL, Bartlett JD, Stashenko P, Taubman MA, Kawai T.
    Exp Cell Res; 2011 Jun 10; 317(10):1454-64. PubMed ID: 21420951
    [Abstract] [Full Text] [Related]

  • 22. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
    Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam KH, Kim Y, Han SB, Yu J, Rho J, Kang JS.
    Mar Drugs; 2014 Nov 24; 12(11):5643-56. PubMed ID: 25421321
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N, Kondo Y, Odkhuu E, Ulziisaikhan J, Ukaji T, Yokochi T, Umezawa K.
    Immunol Lett; 2014 Sep 24; 161(1):31-7. PubMed ID: 24792671
    [Abstract] [Full Text] [Related]

  • 24. Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways.
    Sapkota M, Li L, Choi H, Gerwick WH, Soh Y.
    Eur J Pharmacol; 2015 Dec 15; 769():100-9. PubMed ID: 26550952
    [Abstract] [Full Text] [Related]

  • 25. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M.
    J Bone Miner Res; 2011 Mar 15; 26(3):644-56. PubMed ID: 20814972
    [Abstract] [Full Text] [Related]

  • 26. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
    Chen T, Knapp AC, Wu Y, Huang J, Lynch JS, Dickson JK, Lawrence RM, Feyen JH, Agler ML.
    Assay Drug Dev Technol; 2006 Aug 15; 4(4):387-96. PubMed ID: 16945012
    [Abstract] [Full Text] [Related]

  • 27. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
    Kimachi K, Kajiya H, Nakayama S, Ikebe T, Okabe K.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar 15; 383(3):297-308. PubMed ID: 21225243
    [Abstract] [Full Text] [Related]

  • 28. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S, Hirano S, Kayama F.
    Toxicology; 2004 Oct 15; 203(1-3):211-20. PubMed ID: 15363596
    [Abstract] [Full Text] [Related]

  • 29. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH, Darvin P, Kang DY, Sp N, Byun HJ, Lee CH, Lee HK, Yang YM.
    PLoS One; 2016 Oct 15; 11(7):e0159891. PubMed ID: 27447722
    [Abstract] [Full Text] [Related]

  • 30. Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-κB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-κB-induced RAW264.7 cells.
    Wang X, Zhu Y, Zheng S, Ni C, Zhao L, Liu C, Chen A, Xiao J.
    Mol Med Rep; 2015 May 15; 11(5):3451-6. PubMed ID: 25592168
    [Abstract] [Full Text] [Related]

  • 31. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY, Lin HY, Fong YC, Wu JB, Chen YF, Tsuzuki M, Tang CH.
    Eur J Pharmacol; 2008 Jun 24; 588(1):124-33. PubMed ID: 18495114
    [Abstract] [Full Text] [Related]

  • 32. Silk fibroin hydrolysate inhibits osteoclastogenesis and induces apoptosis of osteoclasts derived from RAW 264.7 cells.
    Chon JW, Kim H, Jeon HN, Park K, Lee KG, Yeo JH, Kweon H, Lee HS, Jo YY, Park YK.
    Int J Mol Med; 2012 Nov 24; 30(5):1203-10. PubMed ID: 22960876
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of andrographolide in RAW 264.7 murine macrophage osteoclastogenesis by downregulating the nuclear factor-kappaB signaling pathway.
    Ren YQ, Zhou YB.
    Genet Mol Res; 2015 Dec 07; 14(4):15955-61. PubMed ID: 26662387
    [Abstract] [Full Text] [Related]

  • 34. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS, Suh KS, Sul D, Kim BJ, Lee SK, Jung WW.
    Int J Mol Med; 2012 Feb 07; 29(2):169-77. PubMed ID: 22038020
    [Abstract] [Full Text] [Related]

  • 35. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H, Zhao L, Cao H, Chen A, Xiao J.
    FASEB J; 2015 Mar 07; 29(3):1092-101. PubMed ID: 25466887
    [Abstract] [Full Text] [Related]

  • 36. I‑BET151 inhibits osteoclastogenesis via the RANKL signaling pathway in RAW264.7 macrophages.
    Cheng J, Zheng J, Guo N, Zi F.
    Mol Med Rep; 2017 Dec 07; 16(6):8406-8412. PubMed ID: 28983590
    [Abstract] [Full Text] [Related]

  • 37. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.
    Int Immunopharmacol; 2007 Dec 05; 7(12):1507-16. PubMed ID: 17920527
    [Abstract] [Full Text] [Related]

  • 38. Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling.
    Mazière C, Louvet L, Gomila C, Kamel S, Massy Z, Mazière JC.
    J Cell Physiol; 2009 Dec 05; 221(3):572-8. PubMed ID: 19725047
    [Abstract] [Full Text] [Related]

  • 39. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
    Lee HY, Jeon HS, Song EK, Han MK, Park SI, Lee SI, Yun HJ, Kim JR, Kim JS, Lee YC, Kim SI, Kim HR, Choi JY, Kang I, Kim HY, Yoo WH.
    Arthritis Rheum; 2006 Jun 05; 54(6):1747-58. PubMed ID: 16736517
    [Abstract] [Full Text] [Related]

  • 40. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW.
    Cell Death Differ; 2004 Jul 05; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.